Rejecting unnecessary patents on key TB drug

After years of advocacy to increase access to the lifesaving tuberculosis (TB) drug bedaquiline, Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes Johnson & Johnson’s (J&J) announcement to drop its secondary patents on the medicine. This decision means additional drugmakers will be allowed to make more affordable generic versions of the drug for people in low-…